Aurobindo nabs 2 honors at Global Generics and Biosimilars Awards

Aurobindo Pharma won two awards at the recent Global Generics and Biosimilars Awards 2019. The Hyderabad, India-based generics and active pharmaceutical ingredients manufacturer took home the Company of the Year and Acquisition of the Year awards at the event, which was held Nov. 5 in Frankfurt, Germany. 

The company earned the Company of the Year award for its development, innovation and success over the past year, and the Acquisition of the Year award was given for its buying of Sandoz’s American dermatology and oral solids businesses. 

"We are delighted and honored to be recognized once again at the Generics & Biosimilars Awards 2019, winning one of the most coveted prizes this year — the Company of the Year award,” said V. Muralidharan, the president of European Operations at Aurobindo. “Together with the Acquisition of the Year award, these awards are an endorsement of our strategy to strengthen and grow our global business and expand and enhance our product portfolio offerings. I would like to thank the many teams for all their hard work and congratulate them for the success achieved to date.”